
SHANDONG TEAMGENE TECHNOLOGY CO., LTD. — Investor Relations & Filings
Shandong Teamgene Technology Co., Ltd. specializes in the research, development, and manufacturing of advanced veterinary diagnostic products and molecular biology reagents. The company focuses on providing comprehensive solutions for animal health management, particularly in the detection and control of infectious diseases in livestock and poultry. Its product portfolio includes high-precision PCR test kits, nucleic acid extraction systems, and rapid diagnostic reagents designed for pathogens such as African Swine Fever and avian influenza. Teamgene serves a diverse clientele, including large-scale breeding enterprises, veterinary laboratories, and animal epidemic prevention centers. By leveraging biotechnology innovations, the company delivers technical support and diagnostic tools aimed at improving biosecurity and animal welfare within the agricultural sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 山东邦基科技股份有限公司2025年第三次临时股东大会会议资料 | 2025-09-23 | Chinese | |
| 山东邦基科技股份有限公司重大信息内部报告制度(2025年9月修订) | 2025-09-15 | Chinese | |
| 山东邦基科技股份有限公司对外投资管理制度(2025年9月修订) | 2025-09-15 | Chinese | |
| 山东邦基科技股份有限公司章程(2025年9月修订) | 2025-09-15 | Chinese | |
| 山东邦基科技股份有限公司关于取消监事会、修订《公司章程》及修订、制定公司部分治理制度的公告 | 2025-09-15 | Chinese | |
| 山东邦基科技股份有限公司第二届董事会第十五次会议决议公告 | 2025-09-15 | Chinese |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39559964 | 山东邦基科技股份有限公司2025年第三次临时股东大会会议资料 | 2025-09-23 | Chinese | ||
| 39559954 | 山东邦基科技股份有限公司重大信息内部报告制度(2025年9月修订) | 2025-09-15 | Chinese | ||
| 39559943 | 山东邦基科技股份有限公司对外投资管理制度(2025年9月修订) | 2025-09-15 | Chinese | ||
| 39559920 | 山东邦基科技股份有限公司章程(2025年9月修订) | 2025-09-15 | Chinese | ||
| 39559906 | 山东邦基科技股份有限公司关于取消监事会、修订《公司章程》及修订、制定公司部分治理制度的公告 | 2025-09-15 | Chinese | ||
| 39559895 | 山东邦基科技股份有限公司第二届董事会第十五次会议决议公告 | 2025-09-15 | Chinese | ||
| 39559887 | 山东邦基科技股份有限公司第二届监事会第十三次会议决议公告 | 2025-09-15 | Chinese | ||
| 39559877 | 山东邦基科技股份有限公司投资者关系管理制度(2025年9月修订) | 2025-09-15 | Chinese | ||
| 39559862 | 山东邦基科技股份有限公司信息披露管理制度(2025年9月修订) | 2025-09-15 | Chinese | ||
| 39559853 | 山东邦基科技股份有限公司董事和高级管理人员所持公司股份及其变动管理制度(2025年9月修订) | 2025-09-15 | Chinese | ||
| 39559838 | 山东邦基科技股份有限公司内幕信息知情人登记管理制度(2025年9月修订) | 2025-09-15 | Chinese | ||
| 39559832 | 山东邦基科技股份有限公司信息披露暂缓与豁免业务内部管理制度(2025年9月修订) | 2025-09-15 | Chinese | ||
| 39559828 | 山东邦基科技股份有限公司董事会秘书工作制度(2025年9月修订) | 2025-09-15 | Chinese | ||
| 39559821 | 山东邦基科技股份有限公司独立董事工作制度(2025年9月修订) | 2025-09-15 | Chinese | ||
| 39559813 | 山东邦基科技股份有限公司对外担保管理制度(2025年9月修订) | 2025-09-15 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
SHANDONG TEAMGENE TECHNOLOGY CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57461/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57461 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57461 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57461 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57461}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SHANDONG TEAMGENE TECHNOLOGY CO., LTD. (id: 57461)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.